Role of PKR and Type I IFNs in Viral Control during Primary and Secondary Infection

English version České info

Type I interferons (IFNs) are known to mediate viral control, and also promote survival and expansion of virus-specific CD8⁺ T cells. However, it is unclear whether signaling cascades involved in eliciting these diverse cellular effects are also distinct. One of the best-characterized anti-viral signaling mechanisms of Type I IFNs is mediated by the IFN-inducible dsRNA activated protein kinase, PKR. Here, we have investigated the role of PKR and Type I IFNs in regulating viral clearance and CD8⁺ T cell response during primary and secondary viral infections. Our studies demonstrate differential requirement for PKR, in viral control versus elicitation of CD8⁺ T cell responses during primary infection of mice with lymphocytic choriomeningitis virus (LCMV). PKR-deficient mice mounted potent CD8⁺ T cell responses, but failed to effectively control LCMV. The compromised LCMV control in the absence of PKR was multifactorial, and linked to less effective CD8⁺ T cell-mediated viral suppression, enhanced viral replication in cells, and lower steady state expression levels of IFN-responsive genes. Moreover, we show that despite normal expansion of memory CD8⁺ T cells and differentiation into effectors during a secondary response, effective clearance of LCMV but not vaccinia virus required PKR activity in infected cells. In the absence of Type I IFN signaling, secondary effector CD8⁺ T cells were ineffective in controlling both LCMV and vaccinia virus replication in vivo. These findings provide insight into cellular pathways of Type I IFN actions, and highlight the under-appreciated importance of innate immune mechanisms of viral control during secondary infections, despite the accelerated responses of memory CD8⁺ T cells. Additionally, the results presented here have furthered our understanding of the immune correlates of anti-viral protective immunity, which have implications in the rational design of vaccines.

Vyšlo v časopise: Role of PKR and Type I IFNs in Viral Control during Primary and Secondary Infection. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000966
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000966

Souhrn

Zdroje

1. BeutlerB

2004 Innate immunity: an overview. Mol Immunol 40 845 859

2. BarberGN

2001 Host defense, viruses and apoptosis. Cell Death Differ 8 113 126

3. SadlerAJ

WilliamsBR

2008 Interferon-inducible antiviral effectors. Nat Rev Immunol 8 559 568

4. BironCA

2001 Interferons alpha and beta as immune regulators–a new look. Immunity 14 661 664

5. Havenar-DaughtonC

KolumamGA

Murali-KrishnaK

2006 Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol 176 3315 3319

6. KolumamGA

ThomasS

ThompsonLJ

SprentJ

Murali-KrishnaK

2005 Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202 637 650

7. Le BonA

ToughDF

2008 Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev 19 33 40

8. LuftT

PangKC

ThomasE

HertzogP

HartDN

1998 Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 161 1947 1953

9. SenGC

PetersGA

2007 Viral stress-inducible genes. Adv Virus Res 70 233 263

10. SamuelCE

2001 Antiviral actions of interferons. Clin Microbiol Rev 14 778 809, table of contents

11. SadlerAJ

WilliamsBR

2007 Structure and function of the protein kinase R. Curr Top Microbiol Immunol 316 253 292

12. KatzeMG

1992 The war against the interferon-induced dsRNA-activated protein kinase: can viruses win? J Interferon Res 12 241 248

13. KatzeMG

1995 Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol 3 75 78

14. KatzeMG

HeY

GaleMJr

2002 Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2 675 687

15. LanglandJO

CameronJM

HeckMC

JancovichJK

JacobsBL

2006 Inhibition of PKR by RNA and DNA viruses. Virus Res 119 100 110

16. CuddihyAR

LiS

TamNW

WongAH

TayaY

1999 Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol 19 2475 2484

17. CuddihyAR

WongAH

TamNW

LiS

KoromilasAE

1999 The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18 2690 2702

18. GrolleauA

KaplanMJ

HanashSM

BerettaL

RichardsonB

2000 Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. J Clin Invest 106 1561 1568

19. HsuLC

ParkJM

ZhangK

LuoJL

MaedaS

2004 The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428 341 345

20. KadereitS

XuH

EngemanTM

YangYL

FairchildRL

2000 Negative regulation of CD8+ T cell function by the IFN-induced and double-stranded RNA-activated kinase PKR. J Immunol 165 6896 6901

21. GarciaMA

MeursEF

EstebanM

2007 The dsRNA protein kinase PKR: virus and cell control. Biochimie 89 799 811

22. GohKC

deVeerMJ

WilliamsBR

2000 The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J 19 4292 4297

23. SureshM

SinghA

FischerC

2005 Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection. J Virol 79 202 213

24. TewariK

NakayamaY

SureshM

2007 Role of direct effects of IFN-gamma on T cells in the regulation of CD8 T cell homeostasis. J Immunol 179 2115 2125

25. van den BroekMF

MullerU

HuangS

ZinkernagelRM

AguetM

1995 Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 148 5 18

26. van den BroekMF

MullerU

HuangS

AguetM

ZinkernagelRM

1995 Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol 69 4792 4796

27. AlsharifiM

MullbacherA

RegnerM

2008 Interferon type I responses in primary and secondary infections. Immunol Cell Biol 86 239 245

28. KhanolkarA

FullerMJ

ZajacAJ

2002 T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus. Immunol Res 26 309 321

29. KumarA

HaqueJ

LacosteJ

HiscottJ

WilliamsBR

1994 Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A 91 6288 6292

30. BironCA

NguyenKB

PienGC

2002 Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr Top Microbiol Immunol 263 7 27

31. OffermannMK

ZimringJ

MellitsKH

HaganMK

ShawR

1995 Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly (I).poly (C) in endothelial cells. Eur J Biochem 232 28 36

32. KaechSM

WherryEJ

2007 Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27 393 405

33. HansenSG

VievilleC

WhizinN

Coyne-JohnsonL

SiessDC

2009 Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15 293 299

34. HusterKM

StembergerC

BuschDH

2006 Protective immunity towards intracellular pathogens. Curr Opin Immunol 18 458 464

35. StembergerC

HusterKM

BuschDH

2006 Defining correlates of T cell protection against infection. Discov Med 6 148 152

36. StembergerC

NeuenhahnM

BuchholzVR

BuschDH

2007 Origin of CD8+ effector and memory T cell subsets. Cell Mol Immunol 4 399 405

37. MullerU

SteinhoffU

ReisLF

HemmiS

PavlovicJ

1994 Functional role of type I and type II interferons in antiviral defense. Science 264 1918 1921

38. RodriguezJR

RodriguezD

EstebanM

1991 Interferon treatment inhibits early events in vaccinia virus gene expression in infected mice. Virology 185 929 933

39. WilliamsBR

2001 Signal integration via PKR. Sci STKE 2001 RE2

40. SamuelCE

1993 The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J Biol Chem 268 7603 7606

41. YeungMC

ChangDL

CamantigueRE

LauAS

1999 Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. Proc Natl Acad Sci U S A 96 11860 11865

42. YeungMC

LauAS

1998 Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells. J Biol Chem 273 25198 25202

43. Chawla-SarkarM

LindnerDJ

LiuYF

WilliamsBR

SenGC

2003 Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8 237 249

44. NallagatlaSR

HwangJ

ToroneyR

ZhengX

CameronCE

2007 5′-triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318 1455 1458

45. ShenH

SlifkaMK

MatloubianM

JensenER

AhmedR

1995 Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A 92 3987 3991

46. RymanKD

WhiteLJ

JohnstonRE

KlimstraWB

2002 Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis. Viral Immunol 15 53 76

47. ParkJH

YuQ

ErmanB

AppelbaumJS

Montoya-DurangoD

2004 Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21 289 302

48. YamajiK

NabeshimaS

MurataM

ChongY

FurusyoN

2006 Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment. Cancer Immunol Immunother 55 394 403

49. NguyenKB

Salazar-MatherTP

DalodMY

Van DeusenJB

WeiXQ

2002 Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169 4279 4287

50. DurbinJE

Fernandez-SesmaA

LeeCK

RaoTD

FreyAB

2000 Type I IFN modulates innate and specific antiviral immunity. J Immunol 164 4220 4228

51. ZhangX

SunS

HwangI

ToughDF

SprentJ

1998 Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8 591 599

52. TakaokaA

YanaiH

KondoS

DuncanG

NegishiH

2005 Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434 243 249

53. HondaK

TaniguchiT

2006 IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6 644 658

54. TakaokaA

YanaiH

2006 Interferon signalling network in innate defence. Cell Microbiol 8 907 922

55. PerdigueroB

EstebanM

2009 The interferon system and vaccinia virus evasion mechanisms. J Interferon Cytokine Res 29 581 598

56. YangYL

ReisLF

PavlovicJ

AguzziA

SchaferR

1995 Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. Embo J 14 6095 6106

57. AhmedR

SalmiA

ButlerLD

ChillerJM

OldstoneMB

1984 Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 160 521 540

58. WhittonJL

SouthernPJ

OldstoneMB

1988 Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 162 321 327

59. Murali-KrishnaK

AltmanJD

SureshM

SourdiveDJ

ZajacAJ

1998 Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8 177 187

60. InabaK

InabaM

RomaniN

AyaH

DeguchiM

1992 Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176 1693 1702

61. MillerNE

BonczykJR

NakayamaY

SureshM

2005 Role of thymic output in regulating CD8 T-cell homeostasis during acute and chronic viral infection. J Virol 79 9419 9429